Advances in CLOT Treatment (ACT)
A Textbook of Cardiology
Will be published approx. on 25. March 2023
Book
Hardback
980 pages
978-93-5696-094-7 (ISBN)
More details
Language
English
Place of publication
New Delhi
India
Target group
College/higher education
Dimensions
Height: 279 mm
Width: 216 mm
ISBN-13
978-93-5696-094-7 (9789356960947)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
HK Chopra
Senior Consultant Cardiologist, Medanta-Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand Medcity
Navin C Nanda
Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, Alabama, USA
Jagat Narula
Executive Vice President, Chief Academic Officer, UT Health, Houston, Texas, USA ; President-Elect, World Heart Federation
GS Wander
Professor and Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India; Past President, API
Viveka Kumar
Principal Director and Chief of Cath Labs, Pan Max Hospitals, Max Heart and Vascular Institute, Saket, New Delhi, India
CN Manjunath
Professor of Cardiology, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, India
CK Ponde
Head, Department of Cardiology, PD Hinduja National Hospital, Mumbai, Maharashtra, India; Past President, IAE
AK Pancholia
Head, Department of Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India
Senior Consultant Cardiologist, Medanta-Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand Medcity
Navin C Nanda
Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, Alabama, USA
Jagat Narula
Executive Vice President, Chief Academic Officer, UT Health, Houston, Texas, USA ; President-Elect, World Heart Federation
GS Wander
Professor and Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India; Past President, API
Viveka Kumar
Principal Director and Chief of Cath Labs, Pan Max Hospitals, Max Heart and Vascular Institute, Saket, New Delhi, India
CN Manjunath
Professor of Cardiology, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, India
CK Ponde
Head, Department of Cardiology, PD Hinduja National Hospital, Mumbai, Maharashtra, India; Past President, IAE
AK Pancholia
Head, Department of Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India
Content
SECTION 1: CLINICAL
SECTION 2: DIAGNOSIS
SECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENT
SECTION 4: NOACs IN CLOT TREATMENT
SECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASE
SECTION 6: THROMBOSIS AND HYPERTENSION
SECTION 7: THROMBOSIS AND HEART FAILURE
SECTION 8: THROMBOSIS AND DYSLIPIDEMIA
SECTON 9: THROMBOSIS AND DIABETES MELLITUS
SECTION 10: THROMBOSIS AND ARRHYTHMIA
SECTION 11: THROMBOSIS AND CARDIOMYOPATHY
SECTION 12: THROMBOSIS AND RHD
SECTION 13: DVT
SECTION 14: THROMBOSIS AND PAD
SECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASE
SECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASE
SECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASE
SECTION 18: THROMBOSIS AND KIDNEY
SECTION 19: THROMBOSIS AND CARDIAC SURGERY
SECTION 20: THROMBOSIS AND CRITICAL CARE
SECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARE
SECTION 22: THROMBOSIS AND SEPSIS
SECTION 23: THROMBOSIS AND WOMEN
SECTION 24: THROMBOSIS AND EYE
SECTION 25: THROMBOSIS AND LUNG
SECTION 26: NOAC AND DRUGS INTERACTION
SECTION 27: COVID-INFLICTED COAGULOPATHY
SECTION 28: CLOT IN ECMO
SECTION 29: THROMBOSIS AND COVID VACCINATION
SECTION 30: THROMBOSIS AND NUTRITION
SECTION 31: CARDIO-ONCOLOGY AND THROMBOSIS
SECTION 32: POSTMITRAL CLIP THROMBOSIS
SECTION 33: PEDIATRICS AND THROMBOSIS
SECTION 34: SKIN AND THROMBOSIS
SECTION 35: THROMBOSIS AND AVN
SECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE
SECTION 2: DIAGNOSIS
SECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENT
SECTION 4: NOACs IN CLOT TREATMENT
SECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASE
SECTION 6: THROMBOSIS AND HYPERTENSION
SECTION 7: THROMBOSIS AND HEART FAILURE
SECTION 8: THROMBOSIS AND DYSLIPIDEMIA
SECTON 9: THROMBOSIS AND DIABETES MELLITUS
SECTION 10: THROMBOSIS AND ARRHYTHMIA
SECTION 11: THROMBOSIS AND CARDIOMYOPATHY
SECTION 12: THROMBOSIS AND RHD
SECTION 13: DVT
SECTION 14: THROMBOSIS AND PAD
SECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASE
SECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASE
SECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASE
SECTION 18: THROMBOSIS AND KIDNEY
SECTION 19: THROMBOSIS AND CARDIAC SURGERY
SECTION 20: THROMBOSIS AND CRITICAL CARE
SECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARE
SECTION 22: THROMBOSIS AND SEPSIS
SECTION 23: THROMBOSIS AND WOMEN
SECTION 24: THROMBOSIS AND EYE
SECTION 25: THROMBOSIS AND LUNG
SECTION 26: NOAC AND DRUGS INTERACTION
SECTION 27: COVID-INFLICTED COAGULOPATHY
SECTION 28: CLOT IN ECMO
SECTION 29: THROMBOSIS AND COVID VACCINATION
SECTION 30: THROMBOSIS AND NUTRITION
SECTION 31: CARDIO-ONCOLOGY AND THROMBOSIS
SECTION 32: POSTMITRAL CLIP THROMBOSIS
SECTION 33: PEDIATRICS AND THROMBOSIS
SECTION 34: SKIN AND THROMBOSIS
SECTION 35: THROMBOSIS AND AVN
SECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE